Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Fuji
Healthtrust
UBS
Medtronic
US Army
Chubb
McKesson
Dow

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 008453

« Back to Dashboard

NDA 008453 describes ANECTINE, which is a drug marketed by Sandoz Inc and is included in one NDA. It is available from one supplier. Additional details are available on the ANECTINE profile page.

The generic ingredient in ANECTINE is succinylcholine chloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
Summary for 008453
Tradename:ANECTINE
Applicant:Sandoz Inc
Ingredient:succinylcholine chloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 008453
Medical Subject Heading (MeSH) Categories for 008453
Suppliers and Packaging for NDA: 008453
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANECTINE succinylcholine chloride INJECTABLE;INJECTION 008453 NDA Sandoz Inc 0781-3009 N 0781-3009-95
ANECTINE succinylcholine chloride INJECTABLE;INJECTION 008453 NDA Sandoz Inc 0781-3411 N 0781-3411-95

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength500MG/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Dow
Teva
Moodys
Healthtrust
Fuji
QuintilesIMS
Johnson and Johnson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot